Alterola Biotech, Inc. (ABTI)

Alterola Biotech Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	0.08	0	0.01	0.06	0
Cash & Short-Term Investments	0.08	0	0.01	0.06	0
Cash Growth	808.81%	-70.18%	-86.06%	12195.95%	-
Other Receivables	-	-	0.04	0.05	-
Receivables	1.06	-	0.04	0.05	-
Inventory	0	0	0	0	-
Other Current Assets	-	-	-	0.01	-
Total Current Assets	1.15	0	0.05	0.13	0
Other Intangible Assets	0.06	-	12	12	-
Total Assets	1.36	0	12.05	12.13	0
Accounts Payable	0.81	0.83	0.61	0.54	0.1
Accrued Expenses	0.46	0.36	0.26	0.4	0.58
Short-Term Debt	2.35	0.15	1.26	0.1	0.08
Other Current Liabilities	-	-	-	-0	-
Total Current Liabilities	3.62	1.33	2.13	1.04	0.76
Long-Term Debt	-	-	0.15	0.16	-
Total Liabilities	3.62	1.33	2.29	1.2	0.76
Common Stock	1.47	1.38	0.81	0.8	0.75
Additional Paid-In Capital	10.23	9.66	18.93	18.08	-
Retained Earnings	-13.67	-12.42	-10.04	-7.97	-1.5
Comprehensive Income & Other	-0.08	0.04	0.07	0.01	-0.01
Shareholders' Equity	-2.25	-1.33	9.76	10.93	-0.76
Total Liabilities & Equity	1.36	0	12.05	12.13	0
Total Debt	2.35	0.15	1.41	0.26	0.08
Net Cash (Debt)	-2.27	-0.14	-1.4	-0.2	-0.08
Net Cash Per Share	-0.00	-0.00	-0.00	-0.00	-
Filing Date Shares Outstanding	1,460	1,467	762.98	807.05	761.78
Total Common Shares Outstanding	1,467	1,383	807.05	802.63	-
Working Capital	-2.47	-1.33	-2.08	-0.91	-0.76
Book Value Per Share	-0.00	-0.00	0.01	0.01	-
Tangible Book Value	-2.11	-1.33	-2.24	-1.07	-0.76
Tangible Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.